Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Monique Spillman

Concepts (262)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
17
2023
450
1.900
 Why?
Endometrial Neoplasms
5
2015
137
0.870
 Why?
Gynecology
5
2020
49
0.830
 Why?
Genital Neoplasms, Female
2
2020
41
0.780
 Why?
Gene Expression Regulation, Neoplastic
10
2019
830
0.760
 Why?
Cystadenocarcinoma, Serous
4
2021
71
0.730
 Why?
Infection Control
1
2020
47
0.690
 Why?
Ethics, Medical
1
2020
46
0.670
 Why?
Communication
1
2020
246
0.610
 Why?
Conflict of Interest
3
2016
25
0.600
 Why?
Uterus
1
2018
91
0.580
 Why?
Medical Oncology
3
2020
96
0.580
 Why?
Robotics
2
2014
41
0.570
 Why?
Pneumonia, Viral
1
2020
170
0.560
 Why?
Peptides
3
2015
221
0.550
 Why?
Coronavirus Infections
1
2020
179
0.550
 Why?
Receptors, Estrogen
5
2017
130
0.550
 Why?
Medroxyprogesterone Acetate
1
2015
6
0.520
 Why?
Fallopian Tube Neoplasms
2
2013
14
0.520
 Why?
Antineoplastic Agents, Hormonal
1
2015
49
0.500
 Why?
Pandemics
1
2020
564
0.500
 Why?
Glycoproteins
1
2015
115
0.490
 Why?
Gynecologic Surgical Procedures
2
2014
28
0.490
 Why?
Neoplastic Stem Cells
1
2015
100
0.480
 Why?
Antigens, CD
1
2015
216
0.470
 Why?
Adenocarcinoma
2
2015
402
0.470
 Why?
Female
34
2023
26981
0.430
 Why?
Salpingectomy
1
2013
6
0.430
 Why?
MicroRNAs
4
2021
350
0.430
 Why?
Pelvic Neoplasms
1
2013
14
0.420
 Why?
Peritoneal Neoplasms
2
2011
62
0.420
 Why?
General Surgery
1
2014
107
0.420
 Why?
Estrogens
2
2012
222
0.410
 Why?
Clinical Trials as Topic
2
2007
465
0.390
 Why?
Medicare Part B
1
2011
5
0.390
 Why?
Professional Corporations
1
2011
1
0.390
 Why?
Marketing of Health Services
1
2011
7
0.380
 Why?
Reimbursement Mechanisms
1
2011
22
0.380
 Why?
Physicians
2
2016
229
0.380
 Why?
Social Responsibility
1
2011
25
0.380
 Why?
Receptors, Progesterone
4
2015
63
0.380
 Why?
Cell Line, Tumor
11
2016
1399
0.370
 Why?
Trust
1
2011
61
0.370
 Why?
Humans
42
2023
50389
0.360
 Why?
Carcinoma, Large Cell
1
2010
15
0.360
 Why?
Carcinoma, Neuroendocrine
1
2010
23
0.360
 Why?
Interprofessional Relations
1
2011
84
0.360
 Why?
Health Care Reform
1
2010
22
0.350
 Why?
Physician-Patient Relations
1
2011
143
0.340
 Why?
Breast Neoplasms
4
2012
1189
0.330
 Why?
Uterine Neoplasms
2
2019
60
0.300
 Why?
Transplantation, Heterologous
2
2012
75
0.300
 Why?
Uterine Cervical Neoplasms
1
2010
278
0.290
 Why?
Physician's Role
2
2011
48
0.280
 Why?
MAP Kinase Kinase 4
1
2007
29
0.280
 Why?
Apoptosis
5
2016
1094
0.270
 Why?
Genes, Tumor Suppressor
1
2007
73
0.270
 Why?
Advance Directives
1
2007
29
0.270
 Why?
Patient Dropouts
1
2007
51
0.270
 Why?
Gene Expression Regulation, Enzymologic
1
2007
178
0.250
 Why?
Receptors, Transforming Growth Factor beta
1
2005
25
0.250
 Why?
Claudin-4
2
2016
7
0.250
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1003
0.230
 Why?
Ovary
1
2004
114
0.230
 Why?
Hysterectomy
2
2014
88
0.230
 Why?
Epithelial Cells
1
2004
210
0.210
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2017
578
0.210
 Why?
Aged
11
2021
9590
0.210
 Why?
Neoplasm Staging
4
2021
750
0.200
 Why?
Middle Aged
12
2021
12460
0.200
 Why?
Gene Expression Profiling
3
2019
1029
0.200
 Why?
Cisplatin
2
2015
275
0.190
 Why?
Immunohistochemistry
6
2017
975
0.180
 Why?
Cell Movement
3
2016
246
0.180
 Why?
Resource Allocation
1
2020
16
0.180
 Why?
Standard of Care
1
2020
18
0.180
 Why?
Disclosure
2
2016
38
0.170
 Why?
Loss of Heterozygosity
2
2013
77
0.170
 Why?
Lymphatic Metastasis
2
2010
227
0.170
 Why?
Early Detection of Cancer
1
2021
165
0.160
 Why?
Leiomyosarcoma
1
2019
23
0.160
 Why?
Leiomyoma
1
2019
25
0.160
 Why?
Neoplasm Invasiveness
3
2015
269
0.160
 Why?
Xenograft Model Antitumor Assays
4
2012
213
0.160
 Why?
RNA-Binding Proteins
2
2019
120
0.160
 Why?
Informed Consent
3
2004
97
0.150
 Why?
Death
1
2018
21
0.150
 Why?
Living Donors
1
2018
23
0.150
 Why?
Critical Care
1
2020
215
0.150
 Why?
Neoplasms, Glandular and Epithelial
2
2015
41
0.150
 Why?
Palliative Care
1
2020
188
0.150
 Why?
Carcinosarcoma
1
2017
18
0.150
 Why?
Microfilament Proteins
1
2017
42
0.150
 Why?
Sequence Analysis, RNA
1
2017
88
0.140
 Why?
United States
4
2016
4913
0.130
 Why?
Adult
7
2021
13568
0.130
 Why?
Mice, Nude
3
2012
252
0.130
 Why?
Industry
1
2016
17
0.130
 Why?
Keratin-5
1
2015
2
0.130
 Why?
Carrier Proteins
1
2017
302
0.130
 Why?
Receptors, Androgen
1
2015
46
0.130
 Why?
Cell Count
1
2015
147
0.130
 Why?
Cell Proliferation
4
2015
989
0.120
 Why?
Prognosis
4
2017
1979
0.120
 Why?
Neoplasm Seeding
1
2014
4
0.120
 Why?
Genetic Privacy
2
2004
3
0.120
 Why?
Alanine
1
2014
41
0.120
 Why?
Triazines
1
2014
24
0.120
 Why?
Endometrium
1
2014
40
0.110
 Why?
Genes, BRCA2
1
2013
12
0.110
 Why?
Genes, BRCA1
1
2013
19
0.110
 Why?
Mice
6
2016
5688
0.110
 Why?
Insurance, Health, Reimbursement
1
2013
24
0.110
 Why?
Health Care Costs
2
2013
168
0.110
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
7
0.110
 Why?
DNA Methylation
3
2023
551
0.100
 Why?
Risk Reduction Behavior
1
2013
58
0.100
 Why?
Carcinoma, Lobular
1
2012
33
0.100
 Why?
DNA-Binding Proteins
2
2013
424
0.100
 Why?
Paclitaxel
1
2012
83
0.100
 Why?
Lymph Nodes
1
2014
258
0.100
 Why?
Antibodies, Neoplasm
1
2012
28
0.100
 Why?
Coercion
1
2011
6
0.100
 Why?
Judicial Role
1
2011
6
0.100
 Why?
Medicare Payment Advisory Commission
1
2011
2
0.100
 Why?
Personal Autonomy
1
2011
15
0.100
 Why?
Women
1
2011
29
0.100
 Why?
Prejudice
1
2011
40
0.100
 Why?
Politics
1
2011
25
0.090
 Why?
Homeodomain Proteins
1
2012
87
0.090
 Why?
Quality of Health Care
1
2013
184
0.090
 Why?
Violence
1
2011
60
0.090
 Why?
M Phase Cell Cycle Checkpoints
1
2011
4
0.090
 Why?
Taxoids
1
2011
37
0.090
 Why?
RNA, Messenger
2
2012
1101
0.090
 Why?
Selective Estrogen Receptor Modulators
1
2010
23
0.090
 Why?
Organ Specificity
1
2010
109
0.090
 Why?
Immunoenzyme Techniques
1
2010
141
0.090
 Why?
Obstetrics
1
2011
88
0.090
 Why?
Models, Statistical
1
2011
226
0.090
 Why?
Cesarean Section
1
2011
185
0.090
 Why?
Neoplasm Recurrence, Local
1
2014
634
0.090
 Why?
Alcohol Drinking
1
2011
227
0.080
 Why?
Societies, Medical
1
2010
179
0.080
 Why?
Blotting, Western
1
2010
587
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
409
0.080
 Why?
Transfection
2
2012
354
0.080
 Why?
Phosphorylation
2
2008
527
0.080
 Why?
Animals
6
2016
13173
0.080
 Why?
Aging
1
2013
675
0.080
 Why?
Aged, 80 and over
4
2021
3180
0.070
 Why?
Alleles
2
2006
253
0.070
 Why?
Antineoplastic Agents
1
2015
1178
0.070
 Why?
Case-Control Studies
2
2014
1148
0.070
 Why?
Chimera
1
2007
9
0.070
 Why?
CpG Islands
1
2007
106
0.070
 Why?
MAP Kinase Signaling System
1
2007
118
0.070
 Why?
Genomic Imprinting
1
2006
11
0.070
 Why?
Insulin-Like Growth Factor II
1
2006
19
0.070
 Why?
RNA, Untranslated
1
2006
14
0.070
 Why?
Health Services Accessibility
1
2010
420
0.070
 Why?
Base Sequence
1
2007
657
0.060
 Why?
Repetitive Sequences, Amino Acid
1
2005
1
0.060
 Why?
Molecular Sequence Data
1
2007
799
0.060
 Why?
Models, Biological
2
2008
723
0.060
 Why?
North Carolina
1
2005
53
0.060
 Why?
Databases, Nucleic Acid
1
2004
12
0.060
 Why?
Telomerase
1
2004
26
0.060
 Why?
Carcinoma
1
2006
139
0.060
 Why?
Promoter Regions, Genetic
1
2007
467
0.060
 Why?
Polymorphism, Genetic
1
2005
181
0.060
 Why?
RNA Interference
2
2016
178
0.060
 Why?
RNA, Small Interfering
2
2016
210
0.060
 Why?
Tumor Burden
2
2016
131
0.060
 Why?
Cell Survival
2
2016
590
0.060
 Why?
Family Health
1
2004
78
0.050
 Why?
Genetic Counseling
1
2004
41
0.050
 Why?
Genomics
1
2004
284
0.050
 Why?
Epigenesis, Genetic
1
2006
374
0.050
 Why?
Researcher-Subject Relations
1
2002
1
0.050
 Why?
Ethical Review
1
2002
2
0.050
 Why?
Contract Services
1
2002
14
0.050
 Why?
Financial Support
1
2002
3
0.050
 Why?
Genetic Predisposition to Disease
1
2005
509
0.050
 Why?
Biotechnology
1
2002
12
0.050
 Why?
Health Care Sector
1
2002
15
0.050
 Why?
Mice, SCID
2
2012
173
0.050
 Why?
Cell Line
1
2004
1010
0.050
 Why?
Drug Industry
1
2002
38
0.050
 Why?
Research Support as Topic
1
2002
45
0.050
 Why?
Research Subjects
1
2002
50
0.050
 Why?
Neoplasm Grading
1
2021
124
0.050
 Why?
Patient Selection
1
2002
257
0.040
 Why?
Cooperative Behavior
1
2002
226
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
14
0.040
 Why?
Cytoskeletal Proteins
1
2019
49
0.040
 Why?
Risk Assessment
1
2023
1258
0.040
 Why?
Microtubule-Associated Proteins
1
2019
65
0.040
 Why?
Biomedical Research
1
2002
242
0.040
 Why?
Cell Cycle Proteins
1
2019
168
0.040
 Why?
Cohort Studies
1
2021
1426
0.030
 Why?
Sensitivity and Specificity
1
2019
875
0.030
 Why?
Caspase 3
1
2016
93
0.030
 Why?
Retrospective Studies
2
2021
6223
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Diagnosis, Differential
1
2019
1042
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2015
49
0.030
 Why?
HEK293 Cells
1
2015
216
0.030
 Why?
Prospective Studies
1
2021
2414
0.030
 Why?
Exosomes
1
2015
48
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2014
11
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
181
0.030
 Why?
Peritoneal Cavity
1
2014
8
0.030
 Why?
Risk Factors
2
2014
3692
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2014
183
0.030
 Why?
Drug Resistance, Neoplasm
1
2015
318
0.030
 Why?
Disease-Free Survival
1
2014
450
0.030
 Why?
MCF-7 Cells
1
2013
62
0.030
 Why?
Germ-Line Mutation
1
2013
63
0.030
 Why?
Homologous Recombination
1
2013
40
0.030
 Why?
Amino Acid Substitution
1
2013
81
0.030
 Why?
Karyotyping
1
2012
83
0.030
 Why?
Extracellular Matrix Proteins
1
2013
69
0.030
 Why?
Anoikis
1
2012
8
0.030
 Why?
Databases, Factual
1
2016
667
0.030
 Why?
Transduction, Genetic
1
2012
45
0.030
 Why?
Tubulin
1
2012
20
0.030
 Why?
Mice, Inbred NOD
1
2012
94
0.030
 Why?
Tamoxifen
1
2012
59
0.030
 Why?
Signal Transduction
2
2011
1625
0.030
 Why?
DNA Fingerprinting
1
2012
62
0.030
 Why?
Cell Adhesion
1
2012
155
0.030
 Why?
Antibody Specificity
1
2012
35
0.020
 Why?
Amino Acid Sequence
1
2013
579
0.020
 Why?
Perioperative Period
1
2011
22
0.020
 Why?
Tumor Suppressor Protein p53
1
2013
214
0.020
 Why?
Estradiol
1
2012
215
0.020
 Why?
Disease Models, Animal
1
2016
1419
0.020
 Why?
Microtubules
1
2011
41
0.020
 Why?
Cell Cycle Checkpoints
1
2011
30
0.020
 Why?
Gene Expression
1
2013
613
0.020
 Why?
Mitosis
1
2011
88
0.020
 Why?
Regression Analysis
1
2011
396
0.020
 Why?
HeLa Cells
1
2011
257
0.020
 Why?
Disease Progression
1
2012
823
0.020
 Why?
Cells, Cultured
1
2013
1589
0.020
 Why?
Severity of Illness Index
1
2011
963
0.020
 Why?
Progesterone Congeners
1
2008
5
0.020
 Why?
Progesterone
1
2008
59
0.020
 Why?
Mutation
1
2013
1292
0.020
 Why?
Protein Kinases
1
2008
70
0.020
 Why?
Cell Nucleus
1
2008
186
0.020
 Why?
Tumor Cells, Cultured
1
2008
462
0.020
 Why?
Transcriptional Activation
1
2006
121
0.020
 Why?
DNA, Neoplasm
1
2006
146
0.020
 Why?
Protein Structure, Tertiary
1
2006
249
0.020
 Why?
Binding Sites
1
2006
378
0.020
 Why?
Repressor Proteins
1
2006
149
0.010
 Why?
Pregnancy
1
2011
2610
0.010
 Why?
Truth Disclosure
1
2004
14
0.010
 Why?
Genetic Diseases, Inborn
1
2004
23
0.010
 Why?
Male
1
2011
25718
0.010
 Why?
Spillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (262) concept(s)
_
Similar People Expand Description
See all (39) people
_